| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/01/2003 | US20030083268 Isoquinoline compounds having antiinfective activity |
| 05/01/2003 | CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
| 05/01/2003 | CA2464981A1 Quinoline compound |
| 05/01/2003 | CA2464790A1 Treatment of acute myeloid leukemia with indolinone compounds |
| 05/01/2003 | CA2464256A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents |
| 05/01/2003 | CA2464254A1 Inhibitors of post-proline cleaving proteases |
| 05/01/2003 | CA2463975A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 05/01/2003 | CA2463101A1 Azole derivatives and pharmaceutical compositions containing them |
| 05/01/2003 | CA2460680A1 Substituted indazole compounds for the treatment of inflammation |
| 04/30/2003 | CN1414961A Substituted oximes and hydrazones as neurokinin antagonists |
| 04/30/2003 | CN1414960A Substituted piperidines, medicaments containing these compounds, and methods for production thereof |
| 04/30/2003 | CN1414953A Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and 5-hydroxytryptamine |
| 04/30/2003 | CN1414952A Heterocyclic compounds having sulfonic acid |
| 04/30/2003 | CN1414950A Substituted pyrrole Mannich bases to treating paint and allergic reactions |
| 04/30/2003 | CN1414858A Combinations of receptor tyrosine kinase inhibitor with a1-acidic glycoprotein binding organic compound |
| 04/30/2003 | CN1414848A Prevention of plaque rupure by ACAT inhibitors |
| 04/30/2003 | CN1413995A Production method of imidacloprid |
| 04/30/2003 | CN1107066C Diaza-spiro [3,5] nonane derivatives |
| 04/30/2003 | CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists |
| 04/29/2003 | US6555689 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 04/29/2003 | US6555569 Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection |
| 04/29/2003 | US6555561 Diaminopyridine-containing thiourea inhibitors of herpes viruses |
| 04/29/2003 | US6555557 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 04/29/2003 | US6555554 Isoindolines, method of use, and pharmaceutical compositions |
| 04/29/2003 | US6555542 Sulfonamide lactam inhibitors of FXa and method |
| 04/29/2003 | US6555539 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis |
| 04/29/2003 | US6555537 Piperazine derivatives and their use as anti-inflammatory agents |
| 04/29/2003 | US6555533 Specific antitumor activity against breast, colon, lung, prostate cancers and melanomas |
| 04/29/2003 | CA2134347C Thiazole or imidazole derivatives as maillard reaction inhibitors |
| 04/24/2003 | WO2003033490A1 Synthesis of 4-[(z)-(4-bromophenyl)(ethoxyimino)methyl]-1'-[2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'methyl-1,4'bipiperidine |
| 04/24/2003 | WO2003033489A1 Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 04/24/2003 | WO2003033488A1 Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts |
| 04/24/2003 | WO2003033487A1 Piperidine- and piperazineacetamines as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 04/24/2003 | WO2003033486A1 Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 04/24/2003 | WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 04/24/2003 | WO2003033480A1 Lactam derivatives as antagonists for human 11cby receptors |
| 04/24/2003 | WO2003033476A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 04/24/2003 | WO2003033472A1 Quinoline or quinazoline derivatives inhibiting auto- phosphorylation of fibroblast growth factor receptors |
| 04/24/2003 | WO2003033466A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 04/24/2003 | WO2003033457A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 04/24/2003 | WO2003032999A1 Alkyne matrix metalloproteinase inhibitors |
| 04/24/2003 | WO2003032997A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 04/24/2003 | WO2003032994A2 Novel tri-substituted pyrimidines, method for production and use thereof as medicament |
| 04/24/2003 | WO2003032993A1 Use of phosphorodiesterase iv inhibitors |
| 04/24/2003 | WO2003032984A1 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 04/24/2003 | WO2003032981A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032910A2 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | WO2003032903A2 Trisubstituted triazines compounds with antitubulin activity |
| 04/24/2003 | WO2003016282A3 Substituted 1h-dihydropyrazoles, their preparation and use |
| 04/24/2003 | WO2003000679A3 Herbicidal substituted pyridines, method for producing the same and their use as herbicidal agents and plant growth regulators |
| 04/24/2003 | WO2002068406A3 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 04/24/2003 | WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/24/2003 | WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030078438 N-heterocyclicamide compounds; used as anticoagulant agent |
| 04/24/2003 | US20030078432 Novel benzotriazoles anti-inflammatory compounds |
| 04/24/2003 | US20030078431 Biheterocyclic compounds having high anticoagulant activity, used as inhibitors of factor Xa |
| 04/24/2003 | US20030078427 Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 04/24/2003 | US20030078419 For therapy of autoimmune diseases mediated by cathepsin S; for inhibiting the progression of tissue transplant rejection |
| 04/24/2003 | US20030078287 For controlling plant and animal pests |
| 04/24/2003 | US20030078286 For therapy of central nervous system disorders such as anxiety, depression, motor disorders |
| 04/24/2003 | US20030078282 For therapy of allergic dermatitis and atopy in animals and humans |
| 04/24/2003 | US20030078279 For therapy and prophylaxis of pain, central nervous system disorder or the like in mammalian subjects |
| 04/24/2003 | US20030078278 Spiropiperidine compounds as ligands for ORL-1 receptor |
| 04/24/2003 | US20030078276 Matrix metalloproteinase inhibitors |
| 04/24/2003 | US20030078275 For therapy of cancer, diabetes and Alzheimer's disease |
| 04/24/2003 | US20030078274 Method of reducing neuronal injury or apoptosis |
| 04/24/2003 | US20030078271 Pyrimidine and indolone derivatives |
| 04/24/2003 | US20030078265 Inhibitors of nitric oxide synthase (nos) |
| 04/24/2003 | US20030078263 Nonnucleotide compounds which interact with specific structures of dna; anticancer agents |
| 04/24/2003 | US20030078261 Prostaglandin agonists |
| 04/24/2003 | US20030078259 Nicotinic acetylcholine receptor activators; treating neurodegenerative disorders |
| 04/24/2003 | US20030078253 Matrix metalloprotease inhibitors |
| 04/24/2003 | US20030078249 VLA-4 inhibitor compounds |
| 04/24/2003 | US20030078166 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030074833 A hydroxyphenyl-2-benzotriazoles as light stabilizers having ultraviolet light absorbing activity; stabilizer with heat resistance, photostability, oxidation resistance |
| 04/24/2003 | CA2463518A1 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | CA2463511A1 Synthesis of 4-[(z)-(4-bromophenyl)(ethoxyimino)methyl]-1'-[2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'methyl-1,4'bipiperidine |
| 04/24/2003 | CA2463510A1 Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts |
| 04/24/2003 | CA2463509A1 Lactam derivatives as antagonists for human 11cby receptors |
| 04/24/2003 | CA2463508A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 04/24/2003 | CA2463469A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 04/24/2003 | CA2462442A1 Alkyne matrix metalloproteinase inhibitors |
| 04/23/2003 | EP1304329A2 Pyridonecarboxylic acid derivatives and their use as antibacterial agents |
| 04/23/2003 | EP1304324A1 Serotonin reuptake inhibitors |
| 04/23/2003 | EP1304110A2 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/23/2003 | EP1304101A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
| 04/23/2003 | EP1303641A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 04/23/2003 | EP1303509A1 Beta3 adrenergic agonists |
| 04/23/2003 | EP1303508A1 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents |
| 04/23/2003 | EP1303507A1 Pyrimidine derivatives |
| 04/23/2003 | EP1303506A1 6-heteroarylphenanthridines |
| 04/23/2003 | EP1303497A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 04/23/2003 | EP1303496A1 Pyrimidine derivatives |
| 04/23/2003 | EP1303495A1 Substituted 5-alkynyl pyrimidines having neurotrophic activity |
| 04/23/2003 | EP1303491A1 Thrombin inhibitors comprising an aminoisoquinoline group |
| 04/23/2003 | EP1303490A1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 04/23/2003 | EP1303488A1 Piperidine compounds for use as ccr-3 inhibitors |
| 04/23/2003 | EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 04/23/2003 | EP1303485A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |